Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
vascular endothelial growth factor receptor (VEGFR)
Catechuic acid
Glucosylceramide synthase inhibitor PDMP sensitizes chronic myeloid leukemia T315I mutant to Bcr-Abl inhibitor and cooperatively induces glycogen synthase kinase-3-regulated apoptosis
17)/t12-/m0/s1
and caspase-3
17-AAG - CAS# 75747-14-7 10935 vascular endothelial growth factor receptorTanespimycin, also known as 17 AAG, is an orally bioavailable, small molecule inhibitor of several receptor protein tyrosine kinases with potential antiangiogenic and antineoplastic activities. Telatinib binds to and inhibits the vascular endothelial growth factor receptors (VEGFRs) type 2 and 3, platelet derived growth factor receptor beta (PDGFRb) and c Kit, which may result in the inhibition of angiogenesis and cellular proliferation in tumors in
US$ 62.00
US$ 19.99
US$ 19.99
US$ 27.00
US$ 40.00
US$ 49.99
US$ 68.00
US$ 40.00
US$ 85.00
US$ 27.99
US$ 10.99
US$ 14.99